Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
Thus, the effect of genetic polymorphism of the CYP2D6 gene on the efficacy and safety profiles of duloxetine was demonstrated in a group of 118 patients with recurrent depressive disorder.
Authors
- Koporov
- Панкратенко
- Ryzhikova
- Sychev
- Bryun
- Petukhov
- Гришина
- Zastrozhin (ORCID: https://orcid.org/0000-0003-0607-4812)
- Valentin Yurievich Skryabin (ORCID: https://orcid.org/0000-0002-4942-8556)
Institutions
- California Department of Toxic Substances Control (US)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4613
- Citations
- 7
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39